However, in the case of severe COVID-19 patients, a retrospective study has found significantly reduced IL-6 levels in LMWH treated patients, prompting the suggestion that this treatment may partially attenuate COVID-19 induced CS [93]. This evidence concerns the gene IL6 and COVID-19.